CMS Medicare Coverage Gap Discount Program: Call for Public Comment…
The Centers for Medicare and Medicaid (CMS) recently issued a memorandum is to provide Part D sponsors with draft guidance for…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Tag
NEW
VA Proposes Restrictions on Access to Pharmaceutical Representatives
The Department of Veterans Affairs (VA) proposed to amend its regulations regarding access to VA facilities to control the…
Physician Payment Sunshine: The Road Ahead
The Regulation Policy Marketing Access (RPM) Report discussed how the Department of Health & Human Services (HHS) has a tough…
Connecticut Passes Adoption of Codes of Conduct
Last week the Connecticut legislature passed a bill requiring manufactures of pharmaceuticals and medicals devices to adopt a…
Pharmaceutical Reps Seen By Fewer Physicians
At a time when the use of drugs and medicine are increasingly being used to beneficially treat Americans in our health care…
CMSS Code for Interactions with Companies – Too Strict for Some, Not…
Last month, the Council of Medical Specialty Societies (CMSS), which represents 32 leading medical professional societies, with…
The Importance of Clinical Trials
A recent supplement in the Wall Street Journal discussed the importance of clinical trials, and provided an introduction to the…
Treating Elderly Patients: Geriatric Graduate and Continuing Medical…
With all the advances in health care and medicine over the past few decades, it is no wonder that Americans are living longer,…
State Policy: Vermont Senate Rejects Public Reporting of Pharmaceutical…
Looking to wrap up their legislative session by this weekend, the Vermont Senate easily passed a major health care reform bill,…
Physician Payment Sunshine: Local Papers Get in The Act
Taking advantage of the new transparency and disclosure guidelines of several companies (Eli Lilly, Pfizer, GlaxoSmithKline,…